Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
December 17, 2024
Not intended for U.S. and UK Media
Aflibercept 8 mg met primary endpoint in phase III study and demonstrates vision gains with extended treatment intervals in retinal vein occlusion
December 13, 2024
Not intended for U.S. and UK Media
Acoramidis receives positive CHMP opinion for treatment of transthyretin amyloid cardiomyopathy
December 12, 2024
Not intended for U.S. and UK Media
Bayer starts Phase I study with SOS1 inhibitor in patients with advanced KRAS-mutated tumors
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
